Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories
Deals
Features
News
Region
Sectors
Size

US And Canada

CSHL joins Autobahn for more spinouts
Cold Spring Harbor Laboratory will work with Autobahn Labs to propel more early-stage discovery programmes into spinouts.
Rev1 raises another OSU-backed fund
Ohio State University has again thrown its weight behind Rev1 Ventures, whose latest fund also attracted University of Dayton and multiple corporates.
Daily deal net: June 14, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Lilly helps inject $108m into Synthekine
The immuno-oncology therapy developer has amassed at least $190m of overall funding since emerging out of Stanford University.
Sharpen Technologies points towards $14m
Bridge Bank and Multiplier Capital have co-led a $14m funding round for Sharpen Technologies, whose shareholders already include the IU Philanthropic Venture Fund.
UnifyID bands together with Prove
StartX-backed UnifyID has agreed to an acquisition by Prove for an undisclosed amount.
Daily deal net: June 8, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Bayer makes it two for two
Noria Therapeutics and PSMA Therapeutics have both been acquired by Bayer, which will integrate their respective assets into its own oncology portfolio.

Other News

LeoLabs makes space for $65m series B
The low Earth orbit mapping technology provider has raised more than $100m altogether, having picked up series A financing from Weru Investment in 2018.
Stablix surfaces with $63m series A
Stablix Therapeutics has launched with $63m in equity financing to commercialise research pioneered in Henry Colecraft’s laboratory at Columbia University.
Daily deal net: June 3, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Jeeves jibes with series A investors
Stanford has contributed to a $26m series A for Jeeves, which was announced concurrently with a $5m seed round and $100m in debt financing.
Century Therapeutics submits IPO filing
The oncology therapy developer has filed for an IPO just two years after emerging from stealth to advance Harvard and Stanford research.
Daily deal net: May 28, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Editor's Picks

Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Editorial: For the good of investors
As MedWhat scores an initial win in its courtroom battle with Stanford, Paige.ai finds itself in the middle of allegations that its licensing deal with Sloan Kettering was improper.
Big deal: Ambys arrives at $140m investment
Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.
Big deal: QuantumScape fuels up on VW cash
VW will invest $100m in QuantumScape and form a joint venture with the Stanford spinout to develop batteries for long-range electric vehicles.
test reg

Login